Exagen Inc.

Filed a patent for "biomarker selection for machine learning enabled prediction of treatment response" on Wed, October 12, 2022

Filed a patent for "methods for treating and diagnosing systemic lupus erythematosus" on Thu, June 22, 2023

Filed a patent for "methods for diagnosing systemic lupus erythematosus" on Thu, June 22, 2023

Filed a patent for "methods for treating and diagnosing systemic lupus erythematosus by measuring levels of biomarkers, such as erythrocyte-bound c4d, b-lymphocyte-bound c4d, anti-sjogren's syndrome type b antigen, scl-70 antibody, jo-1 antibody, and anti-centromere protein b, in subjects; identifying subjects as having systemic lupus erythematosus based on biomarker levels; and treating subjects for systemic lupus erythematosus" on Thu, July 20, 2023

Filed a patent for "methods for diagnosing systemic lupus erythematosus" on Thu, January 4, 2024

Filed a patent for "methods for diagnosing systemic lupus erythematosus" on Thu, August 29, 2024